- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT03519139
Individual Nutritional Intervention for the Prevention of Readmission Among Geriatric Patients
Individual Nutritional Intervention for the Prevention of Readmission Among Geriatric Patients - a Randomized Clinical Study
연구 개요
상세 설명
Method/Design:
The trial is conducted as a randomized clinical trial, with recruitment of 40 medical geriatric patients (definition: ≥65 years of age with at least two diagnoses, e.g. hypertension, cardiovascular diseases, diabetes, chronic obstructive pulmonary disease, rheumatic diseases or apoplexy). At discharge the test subjects are randomized to receive either individual dietary counseling or standard treatment with follow-up 30 and 60 days after discharge. All data are collected prior to randomization. The intervention consists of three individual dietary counsellings with the aim to ensure sufficient coverage of energy and protein needs of the subjects (the first at the hospital by discharge, then in week 1 and week 3 at the subject's home/the respite care after discharge) and, if necessary, telephone follow-up in weeks 2 and 4 after discharge. The intervention group, if possible, are asked to take photos of all they eat and drink for two days before individual dietary counselling and send the photos electronically to the responsible investigators before the meeting.
Recruitment:
Only admitted patients are included in the trial. Attending physician finds the patients through the Health Platform at Sydsjællands University Hospital. The care staff or the attending physician asks whether the patient is willing to talk with the responsible investigators. The responsible investigators then make personal contact with the geriatric patients while they are hospitalized. Patients will be informed orally and in writing about the trial of the responsible investigators. Patients also receive pamphlets about test subjects rights in a health science research project published by the National Science Ethics Committee with the purpose of giving patients an informed basis to make a decision.
Patients are informed that they can take a family member or friend to the next conversation. Patients receive at least 24 hours of deliberation time, after which they are contacted by the responsible investigators. Patients who wish to participate in the trial are asked to sign a consent statement. This statement is also signed by the responsible investigator who has given the patient oral information about the trial. The subjects are offered a copy of the consent statement. To ensure uninterrupted conversation, conversation will take place in a room without other people or alternatively in the patient's room and a partition will be put of if the patient is not in a room by them self.
Patients who meet the inclusion criteria, wishes to participate in the trial and have signed the consent statement will be contacted again on the date of discharge or the day before, where the trial starts. Test subject may at any time, orally, in writing or by other clear indication, withdraw their consent for participation and withdraw from the trial.
Sample size:
Based on the primary output "readmission/hospitalization of geriatric patients within a month", the sample size is estimated to be at least 20 subjects in the intervention and control groups, respectively. A total of at least 40 subjects.
Statistical analysis:
Hypothesis testing will take place using nonparametric statistical tests, as the data can not be assumed to be normal distribution (Mann-Whitney U and Wilcoxon). Fisher's exact test [M1] is used for analysis of categorical data. Correlations are analyzed using Spermann analysis
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Køge, 덴마크, 4600
- Sjaellands Universitetshospital
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- recruited at Medical Department at Sjælland University Hospital, Køge (sections M1, M2, M6, L1) and discharged to one of following municipalities: Greve, Køge, Roskilde, Solrød and Stevns
- geriatric patients according to the definition
- competent adult and Danish speaking who are able to give written consent
- oral nutrition possible (no tube feeding or intravenous nutrition)
- discharged planned for home or respite care or similar (e.g. family).
Exclusion Criteria:
- diagnosed dementia or under investigation for dementia
- nursing home resident or discharged to nursing homes
- terminal patients
- patients who desire weight loss
- scheduled readmission.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 방지
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: individual dietary counselling
three individual dietary counsellings.
The first at the hospital by discharge, then in week 1 and week 3 at the subject's home/the respite care after discharge and, if necessary, telephone follow-up in weeks 2 and 4 after discharge
|
individual dietary counsellings with the aim to ensure sufficient coverage of energy and protein needs of the test subjects
|
|
간섭 없음: Control
standard counselling provided by the hospital at discharge.
The standard counselling may include nutritional prescription and nutritional plan, but no follow-up to the nutrition plan after the discharge.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
readmission-or hospitalization rate (%)
기간: 30 days after discharge
|
readmission for the same diagnosis as at discharge.
Hospitalization for a new diagnosis
|
30 days after discharge
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
readmission-/hospitalization rate (%)
기간: 60 days after discharge
|
readmission for the same diagnosis as at discharge.
Hospitalization for a new diagnosis
|
60 days after discharge
|
|
number of days between readmission or hospitalization and discharge (days)
기간: 30 and 60 days after discharge
|
date minus date
|
30 and 60 days after discharge
|
|
nutritional status (%)
기간: 30 and 60 days after discharge
|
The proportion of subject who has covered at least 75% of estimated energy and protein needs
|
30 and 60 days after discharge
|
|
functional status (score, points)
기간: 30 and 60 days after discharge
|
Functional recovery score: P-ADL, I-ADL and mobility
|
30 and 60 days after discharge
|
|
Quality of Life (score, points)
기간: 30 and 60 days after discharge
|
EQ-5D-5L
|
30 and 60 days after discharge
|
|
muscle strenght (dyn)
기간: 30 and 60 days after discharge
|
Hand-grip strenght
|
30 and 60 days after discharge
|
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
mortality (%)
기간: 30 and 60 days after discharge
|
% died from any cause
|
30 and 60 days after discharge
|
|
side effects in connection with the intervention (number)
기간: 30 and 60 days after discharge
|
any side-effects reported
|
30 and 60 days after discharge
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Jens Rikardt Andersen, ass. prof., University of Copenhagen
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- H-17039329
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
IPD 공유 기간
IPD 공유 액세스 기준
IPD 공유 지원 정보 유형
- 연구 프로토콜
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
미국에서 제조되어 미국에서 수출되는 제품
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .